A detailed history of Accretive Wealth Partners, LLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Accretive Wealth Partners, LLC holds 597 shares of TMO stock, worth $306,977. This represents 0.16% of its overall portfolio holdings.

Number of Shares
597
Previous 626 4.63%
Holding current value
$306,977
Previous $346,000 6.65%
% of portfolio
0.16%
Previous 0.15%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$531.86 - $624.21 $15,423 - $18,102
-29 Reduced 4.63%
597 $369,000
Q1 2024

May 06, 2024

SELL
$528.82 - $599.43 $7,403 - $8,392
-14 Reduced 2.19%
626 $363,000
Q4 2023

Feb 06, 2024

BUY
$431.41 - $532.94 $20,707 - $25,581
48 Added 8.11%
640 $339,000
Q2 2023

Aug 07, 2023

BUY
$508.46 - $591.13 $3,050 - $3,546
6 Added 1.02%
592 $308,000
Q1 2023

May 04, 2023

BUY
$535.0 - $604.82 $1,605 - $1,814
3 Added 0.51%
586 $337,000
Q4 2022

Feb 13, 2023

BUY
$484.71 - $571.37 $84,824 - $99,989
175 Added 42.89%
583 $321,000
Q2 2022

Aug 12, 2022

SELL
$500.9 - $612.21 $4,007 - $4,897
-8 Reduced 1.92%
408 $222,000
Q4 2021

Feb 14, 2022

SELL
$569.0 - $667.24 $5,121 - $6,005
-9 Reduced 2.12%
416 $278,000
Q3 2021

Nov 12, 2021

BUY
$509.53 - $609.78 $13,247 - $15,854
26 Added 6.52%
425 $243,000
Q2 2021

Aug 13, 2021

SELL
$441.0 - $508.24 $31,311 - $36,085
-71 Reduced 15.11%
399 $201,000
Q1 2021

May 17, 2021

SELL
$439.85 - $518.83 $13,195 - $15,564
-30 Reduced 6.0%
470 $214,000
Q4 2020

Feb 12, 2021

SELL
$435.06 - $527.66 $1.47 Million - $1.78 Million
-3,374 Reduced 87.09%
500 $233,000
Q4 2020

Feb 12, 2021

BUY
$435.06 - $527.66 $1.69 Million - $2.04 Million
3,874 New
3,874 $1.8 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $201B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Accretive Wealth Partners, LLC Portfolio

Follow Accretive Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Accretive Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Accretive Wealth Partners, LLC with notifications on news.